Stanley Hazen, MD, PhD, is the Head of the Section for Preventive Cardiology and Rehabilitation, Vice Chair of Translational Research, Lerner Research Institute, Director for the Center for Cardiovascular Diagnostics and Prevention, Director of the Cleveland Clinic Mass Spectrometry Core Facilities, Department Chair in the Department of Cell Biology and Section Head in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic.
Dr. Hazen is board-certified as a Diplomat of the American Board of Internal Medicine. He has also completed subspecialty training in endocrinology, diabetes and metabolism. He sees patients within the Preventive Cardiology Clinic, specializing in preventive cardiovascular medicine care of patients including treatment of hyperlipidemia, diabetes, hypertension, obesity. He also sees patients within the Cardiovascular Rehabilitation program. His research interests include understanding the role of inflammation and oxidant stress in the pathogenesis of atherosclerosis and other inflammatory diseases. He is an expert in mechanisms of atherosclerosis, HDL structure and metabolism, the biochemistry of leukocyte peroxidases, free radicals and reactive oxygen species and mechanisms of oxidative damage.
Dr. Hazen has published over 200 peer-reviewed articles, invited reviews and book chapters in the fields of atherosclerosis, oxidation and inflammation chemistry, and cardiovascular disease. He has received many honors and awards for his research work, which has contributed to new understandings of inflammation in cardiovascular disease and the development of new diagnostic and treatment tools. He is listed as a co-inventor on multiple patents for his work in identifying patients at increased risk for cardiovascular disease, diagnosing asthma, and treating inflammation and associated complications. He has been principal investigator on numerous National Institutes of Health grants and research awards related to his specialty interests.
He serves as reviewer for more than 20 scientific journals including Circulation, Analytical Biochemistry, Journal of Clinical Investigation, Journal of Biological Chemistry and the Journal of Lipid Research. Dr. Hazen is Associate Editor of the Journal of Lipid Research, and serves on the editorial board of Circulation, The Journal of Biological Chemistry and Free Radicals in Biology & Medicine. He has been invited to lecture at national and international symposia and conferences in both basic science and clinical fields alike, as well as workshops held by the National Academy of Science, and National Heart, Lung and Blood Institutes (National Institutes of Health) on Emerging Science for Environmental Health Decisions, mechanisms of atherogenesis, pulmonary immunobiology and inflammation, the origins of asthma, and nitric oxide biology.
Dr. Hazen has received numerous awards including election to membership in honorary societies in science and clinical arenas alike including the American Society for Clinical Investigation (ASCI) and the American Association of Physicians (AAP). He also is an elected fellow of the American Association for the Advancement of Science (AAAS). He holds memberships to the American College of Physicians, the American Federation for Medical Research, the American Heart Association Scientific Council for Arteriosclerosis, the American Medical Association, the American Society for Mass Spectrometry, the International Society for Free Radical Research, the Society for Free Radical Biology & Medicine, and the American Society for Investigative Pathology.